Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
New international report describes the risk factors and outcomes of more than 130 women and nonbinary people.
Canada’s new blood screening policy will not focus on sexual orientation. How does it compare with U.K. and U.S. rules?
What this means for women’s HIV acquisition rates is unclear.
Abnormal anal screening results are common, but they often do not to lead to invasive cancer.
It was previously known as the female condom—until the FDA made these three big regulatory changes.
Stay safe when starting or stopping pre-exposure prophylaxis.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.